Cargando…

Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections

Nucleocapsid serological assay sensitivity to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections among vaccinees and for Omicron cases is unclear. In this prospective study, the Elecsys nucleocapsid assay was 89% sensitive in identifying SARS-CoV-2 infections 14–607 day...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grunau, Brian, Tom, Janessa, Asamoah-Boaheng, Michael, O’Brien, Sheila F, Drews, Steven J, Sediqi, Sadaf, Lavoie, Pascal M, Barakauskas, Vilte, Goldfarb, David M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350617/ https://www.ncbi.nlm.nih.gov/pubmed/35937649 http://dx.doi.org/10.1093/ofid/ofac349

Ejemplares similares

Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals
por: Grunau, Brian, et al.
Publicado: (2022)

Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273
por: Grunau, Brian, et al.
Publicado: (2022)

Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity
por: Asamoah-Boaheng, Michael, et al.
Publicado: (2023)

Effect of vaccine dosing intervals on Omicron surrogate neutralization after three doses of BNT162b2
por: Prusinkiewicz, Martin A., et al.
Publicado: (2023)

Evaluation of the Performance of a Multiplexed Serological Assay in the Detection of SARS-CoV-2 Infections in a Predominantly Vaccinated Population
por: Asamoah-Boaheng, Michael, et al.
Publicado: (2022)

A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic
por: Grunau, Brian, et al.
Publicado: (2022)

Performance evaluation of the Elecsys PIVKA‐II and Elecsys AFP assays for hepatocellular carcinoma diagnosis
por: Chan, Henry L Y, et al.
Publicado: (2022)

Analytical performance evaluation of the Elecsys® Cyclosporine and Elecsys® Tacrolimus assays on the cobas e411 analyzer
por: Sasano, Maki, et al.
Publicado: (2017)

SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study
por: Goldfarb, David M, et al.
Publicado: (2022)

Data on the Relationships of Signal-To-Cutoff Ratios of Elecsys HIV Antigen/Antibody and Elecsys Syphilis Assays to Subsequent Confirmatory Testing at an Academic Medical Center
por: Chopra, Saurav, et al.
Publicado: (2021)

Clinical evaluation of the Roche Elecsys® CMV IgG Avidity assay
por: Vauloup-Fellous, C., et al.
Publicado: (2014)

Clinical Application Evaluation of Elecsys(®) HIV Duo Assay in Southwest China
por: Yang, Mei, et al.
Publicado: (2022)

SARS-CoV-2 cross-sectional seroprevalence study among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, Canada
por: Watts, Allison W, et al.
Publicado: (2023)

Evaluation of Elecsys Syphilis Assay for Routine and Blood Screening and Detection of Early Infection
por: Kremastinou, J., et al.
Publicado: (2016)

Derivation of cutoffs for the Elecsys(®) amyloid β (1–42) assay in Alzheimer's disease
por: Shaw, Leslie M., et al.
Publicado: (2018)

Design and performance characteristics of the Elecsys anti-SARS-CoV-2 S assay
por: Taffertshofer, Karin, et al.
Publicado: (2022)

A method to alleviate false-positive results of the Elecsys HIV combi PT assay
por: Lu, Xiaolan, et al.
Publicado: (2021)

Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
por: Asamoah-Boaheng, Michael, et al.
Publicado: (2022)

Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-S
por: Ahmed, Mohamed I. M., et al.
Publicado: (2023)

SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months
por: Kerr, Colm, et al.
Publicado: (2021)

Evaluation of Elecsys HTLV‐I/II assay in comparison with ARCHITECT rHTLV‐I/II assay with Korean samples
por: Yun, Seung Gyu, et al.
Publicado: (2019)

Evaluation of Sensitivity and Specificity Performance of Elecsys HTLV-I/II Assay in a Multicenter Study in Europe and Japan
por: Laperche, Syria, et al.
Publicado: (2017)

Reduced Relative Sensitivity of the Elecsys SARS-CoV-2 Antigen Assay in Saliva Compared to Nasopharyngeal Swabs
por: Audigé, Annette, et al.
Publicado: (2021)

Cortisol values during the standard-dose cosyntropin stimulation test: Personal experience with Elecsys cortisol II assay
por: Husni, Hasan, et al.
Publicado: (2022)

An Analysis of Predictive Sample-to-Cutoff Index for HIV Infection Confirmation Using Elecsys® HIV Combi PT Assay
por: Xia, Xiaohong, et al.
Publicado: (2022)

Morphological characterization of breeds of sheep: a discriminant analysis approach
por: Asamoah-Boaheng, Michael, et al.
Publicado: (2016)

Comparison of Specific Ovarian Tumor Markers by Elecsys Analyzer 2010
por: Hasanbegovic, Lejla, et al.
Publicado: (2015)

Evaluation of the Elecsys Chagas Assay for Detection of Trypanosoma cruzi-Specific Antibodies in a Multicenter Study in Europe and Latin America
por: Flores-Chavez, Maria Delmans, et al.
Publicado: (2018)

Evaluation of interference effects from hemolysis, icterus and lipemia on the Roche Elecsys® Anti-SARS-CoV-2 assay
por: Tang, Nga-Yeung, et al.
Publicado: (2020)

The evaluation of low cut‐off index values of Elecsys(®) HIV combi PT assay in predicting false‐positive results
por: Tang, Zhuoyun, et al.
Publicado: (2020)

Evaluation of the Elecsys SARS-CoV-2 antigen assay for the detection of SARS-CoV-2 in nasopharyngeal swabs.
por: Ben Abdelhanin, Myriam, et al.
Publicado: (2021)

The Androstenedione Roche Elecsys immunoassay has superior comparability to the LC-MS/MS assay than the Siemens Immulite immunoassay
por: Wei, Ruhan, et al.
Publicado: (2022)

Variation in antibody titers determined by Abbott and Roche Elecsys SARS-CoV-2 assays in vaccinated healthcare workers
por: Nakai, Miku, et al.
Publicado: (2023)

Temporal trends of suicide-related non-traumatic out-of-hospital cardiac arrest characteristics and outcomes with the COVID-19 pandemic
por: Yap, Justin, et al.
Publicado: (2022)

Multicenter evaluation of the Elecsys Toxo IgG and IgM tests for the diagnosis of infection with Toxoplasma gondii
por: Meylan, Pascal, et al.
Publicado: (2015)

Comparison of the Automated Fluorescent Immunoassay System With Roche Elecsys and Beckman Coulter Access 2 Assays for Anti-Müllerian Hormone Measurement
por: Han, Aera, et al.
Publicado: (2022)

ODP036 Cortisol Values During the Standard-Dose Cosyntropin Stimulation Test: Personal Experience with Elecsys Cortisol II Assay
por: Hamrahian, Amir, et al.
Publicado: (2022)

Accuracy Validation of the Elecsys HBsAg II Quant Assay and Its Utility in Resolving Equivocal Qualitative HBsAg Results
por: Lee, Jaehyeon, et al.
Publicado: (2023)

AMHconverter: an online tool for converting results between the different anti-Müllerian hormone assays of Roche Elecsys(®), Beckman Access, and Kangrun
por: Xu, Huiyu, et al.
Publicado: (2023)

Performance of Elecsys Anti-SARS CoV-2 (Roche) and VIDAS Anti-SARS CoV-2 (Biomérieux) for SARS-CoV-2 Nucleocapsid and Spike Protein Antibody Detection
por: Inés, Riberi María, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ck0epnkrarp84oeel3sa2d7v1p